Fractional CO2 Laser Therapy Versus 4% Topical Lidocaine Gel for Dyspareunia in Breast Cancer Survivors
Status:
Recruiting
Trial end date:
2022-06-01
Target enrollment:
Participant gender:
Summary
This trial seeks to determine if therapy with a CO2 laser to the vagina is more effective
than lidocaine to the opening of the vagina before intercourse to reduce painful intercourse
in women who are breast cancer survivors. This study will also be looking at whether or not
the CO2 laser improves pelvic floor function, bowel and bladder function, and sexual function
before and after treatment.